Published in J Anat on October 01, 2010
Renewed focus on the developing human neocortex. J Anat (2010) 1.18
PCB-95 promotes dendritic growth via ryanodine receptor-dependent mechanisms. Environ Health Perspect (2012) 1.12
Associations of cortical thickness and cognition in patients with schizophrenia and healthy controls. Schizophr Bull (2011) 1.11
Arg kinase regulates prefrontal dendritic spine refinement and cocaine-induced plasticity. J Neurosci (2012) 1.11
Abnormalities of the Duo/Ras-related C3 botulinum toxin substrate 1/p21-activated kinase 1 pathway drive myosin light chain phosphorylation in frontal cortex in schizophrenia. Biol Psychiatry (2012) 1.01
Dendritic spine dysgenesis in Rett syndrome. Front Neuroanat (2014) 0.97
The methylazoxymethanol acetate (MAM-E17) rat model: molecular and functional effects in the hippocampus. Neuropsychopharmacology (2011) 0.97
Searching for neuropathology: gliosis in schizophrenia. Biol Psychiatry (2010) 0.95
Developmental origins of brain disorders: roles for dopamine. Front Cell Neurosci (2013) 0.94
Postnatal development of layer III pyramidal cells in the primary visual, inferior temporal, and prefrontal cortices of the marmoset. Front Neural Circuits (2013) 0.93
Synapse-specific contributions in the cortical pathology of schizophrenia. Neurobiol Dis (2013) 0.91
D-serine as a gliotransmitter and its roles in brain development and disease. Front Cell Neurosci (2013) 0.89
Altered serine/threonine kinase activity in schizophrenia. Brain Res (2014) 0.88
The environmental neurotoxicant PCB 95 promotes synaptogenesis via ryanodine receptor-dependent miR132 upregulation. J Neurosci (2014) 0.87
Post-transcriptional regulatory elements and spatiotemporal specification of neocortical stem cells and projection neurons. Neuroscience (2013) 0.86
Schizophrenia and reelin: a model based on prenatal stress to study epigenetics, brain development and behavior. Biol Res (2016) 0.86
BA11 FKBP5 expression levels correlate with dendritic spine density in postmortem PTSD and controls. Neurobiol Stress (2015) 0.86
Age, plasticity, and homeostasis in childhood brain disorders. Neurosci Biobehav Rev (2013) 0.86
Abnormal synaptic pruning in schizophrenia: Urban myth or reality? J Psychiatry Neurosci (2012) 0.84
The neuroimmunology of schizophrenia. Clin Psychopharmacol Neurosci (2013) 0.83
Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia. Schizophr Res (2014) 0.81
Global association between cortical thinning and white matter integrity reduction in schizophrenia. Schizophr Bull (2013) 0.81
Aberrant fetal macrophage/microglial reactions to cytomegalovirus infection. Ann Clin Transl Neurol (2014) 0.80
Brain structure and function correlates of cognitive subtypes in schizophrenia. Psychiatry Res (2015) 0.80
Consequences at adulthood of transient inactivation of the parahippocampal and prefrontal regions during early development: new insights from a disconnection animal model for schizophrenia. Front Behav Neurosci (2014) 0.79
Early prefrontal functional blockade in rats results in schizophrenia-related anomalies in behavior and dopamine. Neuropsychopharmacology (2012) 0.79
Use of T1-weighted/T2-weighted magnetic resonance ratio images to elucidate changes in the schizophrenic brain. Brain Behav (2015) 0.78
Functional hierarchy underlies preferential connectivity disturbances in schizophrenia. Proc Natl Acad Sci U S A (2015) 0.78
New Pharmacotherapy Targeting Cognitive Dysfunction of Schizophrenia via Modulation of GABA Neuronal Function. Curr Neuropharmacol (2015) 0.78
Understanding schizophrenia as a disorder of consciousness: biological correlates and translational implications from quantum theory perspectives. Clin Psychopharmacol Neurosci (2015) 0.77
Similar age-related decline in cortical activity over frontotemporal regions in schizophrenia: a multichannel near-infrared spectroscopy study. Schizophr Bull (2014) 0.76
Subcomponents of brain T2* relaxation in schizophrenia, bipolar disorder and siblings: A Gradient Echo Plural Contrast Imaging (GEPCI) study. Schizophr Res (2015) 0.76
Mice lacking collapsin response mediator protein 1 manifest hyperactivity, impaired learning and memory, and impaired prepulse inhibition. Front Behav Neurosci (2013) 0.76
Valid Statistical Approaches for Analyzing Sholl Data: Mixed Effects versus Simple Linear Models. J Neurosci Methods (2017) 0.75
Mapping the Consequences of Impaired Synaptic Plasticity in Schizophrenia through Development: An Integrative Model for Diverse Clinical Features. Trends Cogn Sci (2017) 0.75
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol (1997) 9.09
Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry (2000) 6.91
Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res (1979) 6.68
The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry (1999) 4.26
Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ (1994) 3.33
Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry (1998) 3.26
Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry (1995) 3.21
Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet (1976) 3.14
Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev (1995) 2.92
Glutamate: a neurotransmitter in mammalian brain. J Neurochem (1984) 2.82
Study of a new schizophrenomimetic drug; sernyl. AMA Arch Neurol Psychiatry (1959) 2.66
Dendritic spine dynamics. Annu Rev Physiol (2009) 2.66
Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach. Trends Neurosci (1996) 2.53
Synaptic development of the cerebral cortex: implications for learning, memory, and mental illness. Prog Brain Res (1994) 2.35
Synaptogenesis in human visual cortex--evidence for synapse elimination during normal development. Neurosci Lett (1982) 2.26
Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry (1992) 2.21
Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry (1992) 2.20
Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol Psychiatry (2006) 1.99
Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch Gen Psychiatry (1979) 1.94
Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology (2008) 1.93
Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry (1993) 1.80
Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res (1994) 1.77
Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J Comp Neurol (1997) 1.74
Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biol Psychiatry (2007) 1.73
Progressive dendritic changes in aging human cortex. Exp Neurol (1975) 1.73
Specific [3H]phencyclidine binding in rat central nervous system. Proc Natl Acad Sci U S A (1979) 1.69
The NMDA receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1. J Neurosci (1994) 1.65
Synapse elimination and plasticity in developing human cerebral cortex. Am J Ment Defic (1984) 1.63
Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry (2005) 1.61
The origin of efferent pathways from the primary visual cortex, area 17, of the macaque monkey as shown by retrograde transport of horseradish peroxidase. J Comp Neurol (1975) 1.61
Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood. Biol Psychiatry (2007) 1.58
Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett (1980) 1.48
Interaction of phencyclidine ("angel dust") with a specific receptor in rat brain membranes. Proc Natl Acad Sci U S A (1979) 1.43
Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J Neuropathol Exp Neurol (2000) 1.40
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry (1989) 1.38
Cerebral ventricular size in twins discordant for schizophrenia. Lancet (1982) 1.37
Decreased numbers of dendritic spines on cortical pyramidal neurons in dementia. A quantitative Golgi study on biopsy samples. Hum Neurobiol (1988) 1.28
Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Expert Rev Neurother (2009) 1.24
Quantitative study on dendrites and dendritic spines in Alzheimer's disease and senile dementia. Adv Neurol (1975) 1.20
Schizophrenia as a developmental disorder of the cerebral cortex. Curr Opin Neurobiol (1998) 1.17
Reduction of cortical volume in schizophrenia on magnetic resonance imaging. Psychol Med (1993) 1.17
The role of microglia in brain injury. Neurotoxicology (1997) 1.12
Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. Am J Psychiatry (1989) 1.11
Limbic pathology in schizophrenia: the entorhinal region--a morphometric study. Biol Psychiatry (1988) 1.11
Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex. J Comp Neurol (1992) 1.09
Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. Folia Neuropathol (2005) 1.08
Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry (1993) 1.08
Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet (1991) 1.06
Prenatal development of neurons in the human prefrontal cortex. II. A quantitative Golgi study. J Comp Neurol (1992) 1.05
Morphometric study of synaptic patterns in the rat caudate nucleus and hippocampus under haloperidol treatment. Synapse (1991) 1.01
Selective distribution of kainate receptor subunit immunoreactivity in monkey neocortex revealed by a monoclonal antibody that recognizes glutamate receptor subunits GluR5/6/7. J Neurosci (1993) 1.01
A family study of the association of increased ventricular size with schizophrenia. Arch Gen Psychiatry (1986) 0.99
Schizophrenia: a disorder of neurodevelopment? Curr Opin Neurobiol (1997) 0.99
A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction. Pharmacol Biochem Behav (1997) 0.95
Decreased numbers of dendritic spines on cortical pyramidal neurons in human chronic alcoholism. Neurosci Lett (1986) 0.95
Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia. Arch Gen Psychiatry (1988) 0.94
The development of dendritic spines in the human visual cortex. Hum Neurobiol (1984) 0.92
Synaptic rearrangements in medial prefrontal cortex of haloperidol-treated rats. Brain Res (1985) 0.90
Imaging as a tool in exploring the neurodevelopment and genetics of schizophrenia. Br Med Bull (1996) 0.88
Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr Bull (1993) 0.88
[Loss of dendritic spines in Alzheimer's disease]. C R Acad Sci III (1990) 0.87
Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics. Exp Brain Res (2006) 0.87
Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression. Aust N Z J Psychiatry (2009) 0.86
Ultrastructural features of biopsied temporopolar cortex (area 38) in a case of schizophrenia. Schizophr Res (1993) 0.86
A comparison of dendritic spine number and type on pyramidal neurons of the visual cortex of old adult rats from social or isolated environments. J Comp Neurol (1982) 0.86
Pyramidal neuron number in layer 3 of primary auditory cortex of subjects with schizophrenia. Brain Res (2009) 0.86
Prenatal development of parvalbumin immunoreactivity in the human striate cortex. Cereb Cortex (1996) 0.85
Prenatal development of NADPH-diaphorase-reactive neurons in human frontal cortex. Cereb Cortex (1997) 0.85
Ventricular enlargement in schizophrenia: definition and prevalence. Am J Psychiatry (1982) 0.85
[Long-term chlorpromazine therapy in animal experiments]. Fortschr Neurol Psychiatr Grenzgeb (1970) 0.83
Prenatal development of calbindin D-28K in human visual cortex. Cereb Cortex (1997) 0.83
Microwave antigen retrieval in formaldehyde-fixed human brain tissue. Methods Mol Biol (1997) 0.80
On the neuropathology of schizophrenia and its dementia: neurodevelopmental, neurodegenerative, or both? Neurodegeneration (1995) 0.80
The dynamics of excitatory synapse formation on dendritic spines. Cellscience (2009) 0.79
Gliosis in schizophrenia. Biol Psychiatry (1988) 0.77